Definition
Cancer screening refers to the identification of subclinical disease in a population through rapid and easy examinations and/or tests. The design and implementation of cancer screening requires the creation of mechanisms for systematic follow-up of individuals with abnormal results, a robust participation of the target population (at least 70%), and the infrastructure to offer the test and to further investigate and/or treat any abnormal findings (World Health Organization 2018; Maxim et al. 2014).
Overview
In 2018, the four most common malignancies among people aged ≥65 years worldwide were those of the lung, colon, prostate, and breast, all of which are susceptible to screening (Ferlay et al. 2018). Ideally, detecting (and treating) cancer at an early stage should lead to a reduction in mortality. However, most randomized controlled trials (RCT) of screening strategies have included...
This is a preview of subscription content, log in via an institution to check access.
References
Baldrick E, Cresswell K, Ellis P et al (2019) Top ten research priorities for detecting cancer early. Lancet Public Health 4:e551. https://doi.org/10.1016/S2468-2667(19)30185-9
Barré S, Massetti M, Leleu H et al (2017) Organised screening for cervical cancer in France: a cost- effectiveness assessment. BMJ Open 7:e014626. https://doi.org/10.1136/bmjopen-2016-014626
De Koning H, Van der Alst C, Ten Haaf K et al (2018) Effects of volume CT lung cancer screening: mortality results of the NELSON randomised-controlled population based trial [PL02.05]. Presented at the IASLC 19th world conference on lung Cancer
Euhus DM, Addae JK, Snyder CF et al (2019) Change in health-related quality of life in older women after diagnosis of a small breast cancer. Cancer 125(11):1807–1814. https://doi.org/10.1002/cncr.31993
Ferlay J, Ervik M, Lam F et al (2018) Global cancer observatory: cancer today. International Agency for Research on Cancer, Lyon. Available from: https://gco.iarc.fr/today. Accessed 31 Jan 19.
Harris R, Leininger L (1995) Clinical strategies for breast cancer screening: weighing and using the evidence. Ann Intern Med 122:539–547. https://doi.org/10.7326/0003-4819-122-7-199504010-00011.
Independent UK Panel on Breast Cancer Screening (2012) The benefits and harms of breast cancer screening: an independent review. Lancet 380:1778–1786. https://doi.org/10.1016/S0140-6736(12)61611-0
Kim JJ, Campos NG, Sy S et al (2015) Inefficiencies and high-value improvements in the U.S. cervical cancer screening practice: a cost-effectiveness analysis. Ann Intern Med 163:589–597. https://doi.org/10.7326/M15-0420
Kotwal AA, Schonberg MA (2017) Cancer screening in the elderly: a review of breast, colorectal, lung, and prostate cancer screening. Cancer 23:246–253. https://doi.org/10.1097/PPO.0000000000000274
Lansdorp-Vogelaar I, Gulati R, Mariotto AB et al (2014) Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits. Ann Intern Med 161:104–112. https://doi.org/10.7326/M13-2867
Lauby-Secretan B, Vilahur N, Bianchini F et al (2018) The IARC perspective on colorectal cancer screening. N Engl J Med 378:1734–1740. https://doi.org/10.1056/NEJMsr1714643
Lee SJ, Boscardin J, Stijacic-Cenzer I (2013) Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark. BMJ 36:e8441. https://doi.org/10.1136/bmj.e8441
Lee CS, Moy L, Joe BN et al (2018) Screening for breast cancer in women age 75 years and older. Am J Roentgenol 210:256–263
Maxim LD, Niebo R, Utell MJ (2014) Screening tests: a review with examples. Inhal Toxicol 26:811–828. https://doi.org/10.3109/08958378.2014.955932
Mazzone PJ, Silvestri GA, Patel S et al (2018) Screening for lung cancer: CHEST guideline and expert panel report. Chest 153:954–985. https://doi.org/10.1016/j.chest.2018.01.016.
McKinney SM, Sieniek M, Godbole V et al (2020) International evaluation of an AI system for breast cancer screening. Nature 577:89–94. https://doi.org/10.1038/s41586-019-1799-6
Melnikow J, Henderson JT, Burda BU et al (2018) Screening for cervical cancer with high-risk human papillomavirus testing: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 320:687–705. https://doi.org/10.1001/jama.2018.10400
National Lung Cancer Screening Trial Research Team (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395–409. https://doi.org/10.1056/NEJMoa1102873
Nelson HD, Fu R, Cantor A et al (2016) Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 U.S. Preventive Services Task Force recommendation. Ann Intern Med 164:244–255. https://doi.org/10.7326/M15-0969
Pinsky PF, Miller E, Prorok P et al (2018) Extended follow-up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and Ovarian randomized cancer screening trial. BJU Int. https://doi.org/10.1111/bju.14580
Piper MS, Maratt JK, Zikmund-Fisher BJ et al (2018) Patient attitudes toward individualized recommendations to stop low-value colorectal Cancer screening. JAMA Netw Open 1:e185461. https://doi.org/10.1001/jamanetworkopen.2018.5461
Royce TJ, Hendrix LH, Stokes WA et al (2014) Cancer screening rates in individuals with different life expectancies. JAMA Intern Med 174(10):1558–1565. https://doi.org/10.1001/jamainternmed.2014.3895
Schoenborn NL, Lee K, Pollack CE et al (2017) Older adults’ views and communication preferences about cancer screening cessation. JAMA Intern Med 177(8):1121–1128. https://doi.org/10.1001/jamainternmed.2017.1778
Schonberg MA, Breslau ES, Hamel MB et al (2015) Colon Cancer screening in U.S. adults aged 65 and older according to life expectancy and age. J Am Geriatr Soc 63:750–756. https://doi.org/10.1111/jgs.13335
Schröder FH, Hugosson J, Roobol MJ et al (2014) Screening and prostate cancer mortality: results of the European randomised study of screening for prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 384:2027–2035. https://doi.org/10.1016/S0140-6736(14)60525-0
Sharma C, Deutsch I, Horowitz DP et al (2012) Patterns of care and treatment outcomes for elderly women with cervical cancer. Cancer 118:3618–3626. https://doi.org/10.1002/cncr.26589
Stacey D, Légaré F, Lewis K et al (2017) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 4:CD001431. https://doi.org/10.1002/14651858.CD001431.pub5.
Tang V, Boscardin WJ, Stijacic-Cenzer I et al (2015) Time to benefit for colorectal cancer screening: survival meta-analysis of flexible sigmoidoscopy trials. BMJ 350:h1662. https://doi.org/10.1136/bmj.h1662
Welch HG, Black WC (1997) Evaluating randomized trials of screening. J Gen Intern Med 12:118–124. https://doi.org/10.1046/j.1525-1497.1997.00017.x
Wilt TJ, Brawer MK, Jones KM et al (2012) Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 367:203–213. https://doi.org/10.1056/NEJMoa1615869.
World Health Organization (2018) Early diagnosis and screening: screening. WHO, Geneva. Available from: https://www.who.int/cancer/prevention/diagnosis-screening/screening/en/. Accessed 01 Jan 2020
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Verduzco-Aguirre, H.C., Navarrete-Reyes, A.P., Chavarri-Guerra, Y., Soto-Perez-de-Celis, E. (2020). Cancer Screening. In: Gu, D., Dupre, M. (eds) Encyclopedia of Gerontology and Population Aging. Springer, Cham. https://doi.org/10.1007/978-3-319-69892-2_759-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-69892-2_759-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-69892-2
Online ISBN: 978-3-319-69892-2
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences